Literature DB >> 19699221

An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon.

Josephine Shenouda1, Paula Green, Lester Sultatos.   

Abstract

Acetylcholinesterase (EC 3.1.1.7) and butyrylcholinesterase (EC 3.1.1.8) are enzymes that belong to the superfamily of alpha/beta-hydrolase fold proteins. While they share many characteristics, they also possess many important differences. For example, whereas they have about 54% amino acid sequence identity, the active site gorge of acetylcholinesterase is considerably smaller than that of butyrylcholinesterase. Moreover, both have been shown to display simple and complex kinetic mechanisms, depending on the particular substrate examined, the substrate concentration, and incubation conditions. In the current study, incubation of butyrylthiocholine in a concentration range of 0.005-3.0 mM, with 317 pM human butyrylcholinesterase in vitro, resulted in rates of production of thiocholine that were accurately described by simple Michaelis-Menten kinetics, with a K(m) of 0.10 mM. Similarly, the inhibition of butyrylcholinesterase in vitro by the organophosphate chlorpyrifos oxon was described by simple Michaelis-Menten kinetics, with a k(i) of 3048 nM(-1) h(-1), and a K(D) of 2.02 nM. In contrast to inhibition of butyrylcholinesterase, inhibition of human acetylcholinesterase by chlorpyrifos oxon in vitro followed concentration-dependent inhibition kinetics, with the k(i) increasing as the inhibitor concentration decreased. Chlorpyrifos oxon concentrations of 10 and 0.3 nM gave k(i)s of 1.2 and 19.3 nM(-1) h(-1), respectively. Although the mechanism of concentration-dependent inhibition kinetics is not known, the much smaller, more restrictive active site gorge of acetylcholinesterase almost certainly plays a role. Similarly, the much larger active site gorge of butyrylcholinesterase likely contributes to its much greater reactivity towards chlorpyrifos oxon, compared to acetylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699221      PMCID: PMC2790002          DOI: 10.1016/j.taap.2009.08.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  41 in total

Review 1.  Neurobiology of butyrylcholinesterase.

Authors:  Sultan Darvesh; David A Hopkins; Changiz Geula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

2.  Conformational diversity and protein evolution--a 60-year-old hypothesis revisited.

Authors:  Leo C James; Dan S Tawfik
Journal:  Trends Biochem Sci       Date:  2003-07       Impact factor: 13.807

3.  Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate.

Authors:  Jure Stojan; Laure Brochier; Carole Alies; Jacques Philippe Colletier; Didier Fournier
Journal:  Eur J Biochem       Date:  2004-04

4.  Substrate activation in acetylcholinesterase induced by low pH or mutation in the pi-cation subsite.

Authors:  Patrick Masson; Lawrence M Schopfer; Cynthia F Bartels; Marie-Thérèse Froment; Fabien Ribes; Florian Nachon; Oksana Lockridge
Journal:  Biochim Biophys Acta       Date:  2002-02-11

5.  Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate.

Authors:  G J Hart; R D O'Brien
Journal:  Biochemistry       Date:  1973-07-17       Impact factor: 3.162

6.  Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor.

Authors:  W Liu; C L Tsou
Journal:  Biochim Biophys Acta       Date:  1986-03-28

7.  Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion.

Authors:  Jure Stojan; Marko Golicnik; Marie-Thérèse Froment; Francois Estour; Patrick Masson
Journal:  Eur J Biochem       Date:  2002-02

8.  High activity of human butyrylcholinesterase at low pH in the presence of excess butyrylthiocholine.

Authors:  Patrick Masson; Florian Nachon; Cynthia F Bartels; Marie-Therese Froment; Fabien Ribes; Cedric Matthews; Oksana Lockridge
Journal:  Eur J Biochem       Date:  2003-01

9.  Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.

Authors:  Joseph L Johnson; Bernadette Cusack; Matthew P Davies; Abdul Fauq; Terrone L Rosenberry
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

10.  Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.

Authors:  Yvain Nicolet; Oksana Lockridge; Patrick Masson; Juan C Fontecilla-Camps; Florian Nachon
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

View more
  11 in total

1.  Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.

Authors:  Toby B Cole; Jenna C Fisher; Thomas M Burbacher; Lucio G Costa; Clement E Furlong
Journal:  Neurotoxicol Teratol       Date:  2012-03-07       Impact factor: 3.763

2.  Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.

Authors:  Toby B Cole; Richard P Beyer; Theo K Bammler; Sarah S Park; Federico M Farin; Lucio G Costa; Clement E Furlong
Journal:  Toxicol Sci       Date:  2011-06-14       Impact factor: 4.849

3.  Combination effects of anticholinesterasics in acetylcholinesterase of a fish species: effects of a metallic compound, an organophosphate pesticide, and a pharmaceutical drug.

Authors:  Bruno Nunes; Ana Raquel Barbosa; Sara C Antunes; Fernando Gonçalves
Journal:  Environ Sci Pollut Res Int       Date:  2014-02-19       Impact factor: 4.223

4.  Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

Authors:  J Allen Crow; Victoria Bittles; Katye L Herring; Abdolsamad Borazjani; Philip M Potter; Matthew K Ross
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-04       Impact factor: 4.219

5.  Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.

Authors:  Eugénie Carletti; Lawrence M Schopfer; Jacques-Philippe Colletier; Marie-Thérèse Froment; Florian Nachon; Martin Weik; Oksana Lockridge; Patrick Masson
Journal:  Chem Res Toxicol       Date:  2011-04-18       Impact factor: 3.739

6.  Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s.

Authors:  Mahendra Pratap Kashyap; Abhishek Kumar Singh; Vivek Kumar; Vinay Kumar Tripathi; Ritesh Kumar Srivastava; Megha Agrawal; Vinay Kumar Khanna; Sanjay Yadav; Swatantra Kumar Jain; Aditya Bhushan Pant
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

7.  Protective efficacy of 2-PAMCl, atropine and curcumin against dichlorvos induced toxicity in rats.

Authors:  Preeti Yadav; Sunil E Jadhav; Vinesh Kumar; Kirtee K Kaul; Satish C Pant; Swaran J S Flora
Journal:  Interdiscip Toxicol       Date:  2012-03

8.  Mouse Model for Assessing the Subchronic Toxicity of Organophosphate Pesticides.

Authors:  V A Palikov; S S Terekhov; Yu A Palikova; O N Khokhlova; V A Kazakov; I A Dyachenko; S V Panteleev; Yu A Mokrushina; V D Knorre; O G Shamborant; I V Smirnov; A G Gabibov
Journal:  Acta Naturae       Date:  2018 Oct-Dec       Impact factor: 1.845

9.  Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.

Authors:  S S Terekhov; I V Smirnov; O G Shamborant; T V Bobik; D G Ilyushin; A N Murashev; I A Dyachenko; V A Palikov; V D Knorre; A A Belogurov; N A Ponomarenko; E S Kuzina; D D Genkin; P Masson; A G Gabibov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

10.  The Effect of Organophosphate Exposure on Neuronal Cell Coenzyme Q10 Status.

Authors:  Nadia Turton; Robert A Heaton; Fahima Ismail; Sioned Roberts; Sian Nelder; Sue Phillips; Iain P Hargreaves
Journal:  Neurochem Res       Date:  2020-04-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.